Bridgepoint tests appetite for $2.2 bln dialysis clinic firm Diaverum - sources

European buyout firm Bridgepoint is exploring a sale or stock market listing of its dialysis clinic operator Diaverum as part of a long-anticipated exit plan that could fetch up to 2 billion euros ($2.23 billion), sources close to the matter told Reuters.